Search details
1.
Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
Prostate
; 82(13): 1264-1272, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35766303
2.
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
Oncologist
; 27(10): e815-e818, 2022 10 01.
Article
in English
| MEDLINE | ID: mdl-36036607
3.
Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer.
Oncologist
; 25(4): 327-333, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32297439
4.
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
Cancer
; 125(9): 1459-1469, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-30620391
5.
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention.
Breast Cancer Res Treat
; 173(3): 559-571, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30368741
6.
A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.
Clin Transl Med
; 14(3): e1627, 2024 03.
Article
in English
| MEDLINE | ID: mdl-38515274
7.
Mediator kinase inhibition reverses castration resistance of advanced prostate cancer.
J Clin Invest
; 134(10)2024 Mar 28.
Article
in English
| MEDLINE | ID: mdl-38546787
8.
A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.
Anticancer Drugs
; 24(7): 743-53, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23652277
9.
Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer.
Front Oncol
; 13: 1202277, 2023.
Article
in English
| MEDLINE | ID: mdl-38450313
10.
Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins.
Biochem J
; 439(2): 299-311, 2011 Oct 15.
Article
in English
| MEDLINE | ID: mdl-21767261
11.
Racial Distribution of Neighborhood-Level Social Deprivation in a Retrospective Cohort of Prostate Cancer Survivors.
Diseases
; 10(4)2022 Oct 03.
Article
in English
| MEDLINE | ID: mdl-36278574
12.
Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts.
Transl Oncol
; 17: 101350, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35091340
13.
Regulation of Skp2 levels by the Pim-1 protein kinase.
J Biol Chem
; 285(38): 29128-37, 2010 Sep 17.
Article
in English
| MEDLINE | ID: mdl-20663873
14.
Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.
Prostate
; 71(7): 755-65, 2011 May 15.
Article
in English
| MEDLINE | ID: mdl-21031435
15.
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.
J Clin Invest
; 118(9): 3038-50, 2008 Sep.
Article
in English
| MEDLINE | ID: mdl-18704194
16.
PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications.
Int J Exp Pathol
; 91(1): 34-43, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-19878356
17.
Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study.
Am J Hematol
; 85(3): 164-70, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-20131302
18.
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer.
Cancer Treat Res Commun
; 24: 100193, 2020.
Article
in English
| MEDLINE | ID: mdl-32702615
19.
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-ß.
Sci Transl Med
; 12(525)2020 01 08.
Article
in English
| MEDLINE | ID: mdl-31915300
20.
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors.
Clin Cancer Res
; 26(11): 2546-2555, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-32034076